[Familial congenital adrenal hyperplasia caused by 11 beta-hydroxylase. Failure of prevention of sexual ambiguity and prenatal diagnosis].

Abstract

In a sepharad family from Morocco, 2 children out of 4 had congenital adrenal hyperplasia with 11 beta-hydroxylase deficiency. The index case had a very severe genital masculinization (Prader V), diagnosed at 18 months of age. For the fourth pregnancy, dexamethasone was given from the 8th to the 24th week of amenorrhea, in order to prevent the virilization of a female fetus. The treatment was interrupted for 5 days, at the 20th week, because of amniocentesis. As the amniotic steroid concentrations were normal, the treatment was stopped. Nevertheless the neonate also has severe virilization of the external genitalia and postnatal hormonal studies confirmed the diagnosis of congenital adrenal hyperplasia due to 11 beta-hydroxylase deficiency. The reasons for the failure of the treatment are analyzed.

• Authors: M Bouchard, M G Forest, M David, H Dechaud, J G Juif
• Journal: Pediatrie (Pediatrie) Vol. 44 Issue 8 Pg. 637-40 ( 1989) ISSN: 0031-4021 [Print] France
• Vernacular Title: Observation familiale d'hyperplasie congénitale des surrénales par déficit en 11 beta-hydroxylase. Echec de la prévention de l'ambiguïté sexuelle et du diagnostic anténatal.
• PMID: 2622705 (Publication Type: Case Reports, English Abstract, Journal Article)

Chemical References

• Dexamethasone
• Steroid Hydroxylases

Topics

• Adrenal Hyperplasia, Congenital (complications, diagnosis, drug therapy)
• Child
• Child, Preschool
• Dexamethasone (therapeutic use)
• Disorders of Sex Development (etiology)
• Female
• Humans
• Infant
• Infant, Newborn
• Pregnancy
• Prenatal Care
• Prenatal Diagnosis
• Steroid Hydroxylases (deficiency)